Guo Yuqian, Chu Lihua, Shui Weiwei, Hu Huiyi, Hao Liman, Wang Dongdong, Song Sengwen, Fang Xiangming, Xie Guohao
Department of Anesthesiology and Intensive Care, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang, China.
Shock. 2025 Jul 14. doi: 10.1097/SHK.0000000000002659.
Sepsis, a life-threatening condition caused by infection, induces dysregulated immune responses. Lactylation is a lactate-derived post-translational modification with roles in various cellular processes. We investigated lactylation levels in the immune cells of patients with sepsis and evaluated their association with disease progression.
In this prospective cohort study, blood samples were collected on days 1 and 3 from 58 intensive care unit patients, including critically ill controls and sepsis patients (survivors and non-survivors). Biochemical and clinical data were analyzed, and immune cells were isolated to measure pan-lysine lactylation (Pan Kla), H4K5la, and H3K56la levels using flow cytometry.
Patients with sepsis exhibited significantly elevated neutrophil H4K5la levels compared with critically ill controls on day 1 (231.6 [174.9 - 361.9] vs. 127.5 [69.4 - 168.9] mean fluorescence intensity [MFI], P < 0.0001); similar trends were observed in monocytes, B cells, and T cells. Multivariate analysis identified neutrophil H4K5la levels as an independent predictor of sepsis. The combination of day 1 neutrophil H4K5la and C-reactive protein (CRP) levels improved diagnostic performance (area under the receiver operating characteristic curve = 0.902 [95% confidence interval, 0.795 - 0.964]). On day 3, non-survivors showed lower lactylation levels than survivors (monocyte Pan Kla: 79.8 [54.9 - 106.1] vs. 133.2 [112.3 - 259.2] MFI, P = 0.0334; T-cell H3K56la: 15.5 [8.2 - 28.1] vs. 37.2 [23.9 - 71.4] MFI, P = 0.0143).
Immune cell lactylation may serve as a biomarker for sepsis progression. The combination of neutrophil H4K5la and CRP enhances early diagnostic accuracy; reduced lactylation on day 3 may indicate poor prognosis.
脓毒症是一种由感染引起的危及生命的病症,可诱导免疫反应失调。乳酰化是一种由乳酸衍生的翻译后修饰,在各种细胞过程中发挥作用。我们研究了脓毒症患者免疫细胞中的乳酰化水平,并评估了它们与疾病进展的关联。
在这项前瞻性队列研究中,于第1天和第3天从58名重症监护病房患者中采集血样,包括危重症对照患者以及脓毒症患者(幸存者和非幸存者)。分析生化和临床数据,并分离免疫细胞,使用流式细胞术测量全赖氨酸乳酰化(Pan Kla)、H4K5la和H3K56la水平。
与第1天的危重症对照患者相比,脓毒症患者的中性粒细胞H4K5la水平显著升高(平均荧光强度[MFI]:231.6[174.9 - 361.9]对127.5[69.4 - 168.9],P < 0.0001);在单核细胞、B细胞和T细胞中也观察到类似趋势。多变量分析确定中性粒细胞H4K5la水平是脓毒症的独立预测指标。第1天中性粒细胞H4K5la水平与C反应蛋白(CRP)水平的联合提高了诊断性能(受试者工作特征曲线下面积 = 0.902[95%置信区间,0.795 - 0.964])。在第3天,非幸存者的乳酰化水平低于幸存者(单核细胞Pan Kla:79.8[54.9 - 106.1]对133.2[112.3 - 259.2]MFI,P = 0.0334;T细胞H3K56la:15.5[8.2 - 28.1]对37.2[23.9 - 71.4]MFI,P = 0.0143)。
免疫细胞乳酰化可能作为脓毒症进展的生物标志物。中性粒细胞H4K5la与CRP的联合提高了早期诊断准确性;第3天乳酰化水平降低可能表明预后不良。